CAS: 33125-05-2; Boc-D-Phg-Oh

该化合物是一种受保护的氨酸,通常用于浸泡物合成和药用化学中,该化合物具有受保护的氨酸,与氨基氨基氨基酯组附属,增加了其稳定性和化学反应过程中的溶解性."D"名称表明它是甲型苯基苯基苯基苯的D-enantomer,其特征是附于甘油结构的甲型碳的苯基.该化合物通常是白色至白的固体,在二氯甲烷和二甲基硫氧化物等有机溶剂中可溶解,但水中溶解性较小.其结构允许在丙基酸链中引入性,使其在生物活性化合物合成过程中具有价值.此外,乙基-D-丙-苯基乙烯基乙烯可以作为制药业发展的一个建筑块,特别是用于设计抑制剂或生物路径的改造剂或化学特性.

结构式图片

相似化合物

3601-66-9 102410-65-1 111524-95-9

欧盟法规

C&L通报

上下游产品

CAS号24424-99-5 二碳酸二叔丁酯 | CAS号875-74-1 D-(-)-α-苯基甘氨酸 | CAS号67341-01-9 N-(叔丁氧羰基)-DL-2-苯甘氨醇 | CAS号762-75-4 甲酸叔丁酯 | CAS号4248-19-5 氨基甲酸叔丁酯 | CAS号100-52-7 苯甲醛 | CAS号150884-50-7 (苯基亚甲基)氨基甲酸叔丁酯 | CAS号155396-71-7 tert-butyl N-[b... | CAS号19883-41-1 D-苯甘氨酸甲酯盐酸盐 | CAS号67341-01-9 N-(叔丁氧羰基)-DL-2-苯甘氨醇 | CAS号875-74-1 D-(-)-α-苯基甘氨酸 | CAS号3577-01-3 头孢来星 | CAS号129157-10-4 (R)-(+)-N-异丙基-1... | CAS号137284-11-8 2-Methyl-2-prop... | CAS号141190-94-5 2-((叔丁氧基羰基)氨基)-...

合成工艺路线路线简述

    苯甲酰硝基甲烷置于ammonium Cerium (Iv) Nitrate,(R)-N-(Phenylcarbamoyl)-Tert-Butanesulfinamide,三氯硅烷,水,四氯化钛,溶剂黄146,三乙胺,Sodium Nitrite体系中,用 二甲基亚砜,甲苯,乙腈 作为反应溶剂,化学反应 72.5H,反应生成 Boc-D-苯甘氨酸
    参考文献:以简单的n-亚磺酰基尿素为双功能催化剂的β-氨基硝基烯烃的高度对映选择性还原
    标题:以简单的n-亚磺酰基尿素为双功能催化剂的β-氨基硝基烯烃的高度对映选择性还原
    摘要:简单但有效:发现结构简单的n-亚磺酰基尿素是一种高效的双功能催化剂,它允许通过三氯硅烷对映体选择性还原β-氨基硝基烯烃来开发构建手性β-氨基硝基链烷烃的新途径.对于广泛的β-芳基氨基硝基烯烃底物,均获得了高收率和出色的对映选择性(参见方案).
    DOI:10.1002/chem.201201192

    海关参考信息

    专利信息


    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-4520193-A
    优先权日:1980-11-20
    标题 :Cephalosporin derivatives
    发明人:BERGER CHRISTIAN; FARGE DANIEL; MOUTONNIER CLAUDE; WOLFF GERARD
    权利人:RHONE POULENC IND
    摘要:The invention provides new cephalosporin derivatives of the general formula, ##STR1## which are in the form of a bicyclooct-2-ene or bicyclooct-3-ene, in which formula R 1 is a radical of the general formula ##STR2## [in which R 5 is hydrogen, alkyl, vinyl, cyanomethyl, protected carboxyalkyl or a protective radical and R 6 is a protective radical] or an amino-protecting radical, R 2 is an acid-protecting radical and R° represents various organic radicals, or alternatively R 1 is an amino-protecting radical or various acyl radicals, R 2 is a protective radical and R° represents various organic radicals, and R 3 and R 4 are alkyl radicals optionally substituted by alkoxy or dialkylamino, or phenyl radicals, or --NR 3 R 4 forms a heterocyclic ring. These products are intermediates for the synthesis of cephalosporins having antibacterial activity.

    专利号:US-3994883-A
    优先权日:1972-12-27
    标 题 :Penicillin and cephalosporin intermediates
    发明人:BORREVANG POUL; GUDDAL ERLING; PETERSEN HENNING BORGE; FAARUP PETER; NIELSEN JORGEN ILUM
    权利人:NOVO INDUSTRI AS
    摘要:Novel penicillin and cephalosporin intermediates for the synthesis of 6-APA or 7-aminocephem compounds involving formation of a 6 or 7 phosphite amido compound and the conversion of such compound to a desired 6-APA or 7-aminocephem compound.

    专利号:US-2004106598-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds
    湖北恒绿源科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hbhlykj.com
    企业联系电话:027-88188016👤
    📞湖北恒绿源科技有限公司 ⚠️参考联系方式
    联系人:高婕
    电话:027-88188016
    手机:18062414339
    传真:027-88188026
    邮箱:sales@hbhlykjtech.com
    通信地址: 湖北省武汉市江岸区黄孝河路182号
    邮编: 430012
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市江岸区黄孝河路182号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    泰州天鸿生化科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.thbiochem.com
    企业联系电话:0523-86201489👤
    📞泰州天鸿生化科技有限公司 ⚠️参考联系方式
    联系人:车胜丽
    电话:0523-86201489
    手机:15366717998
    传真:0523-86201489
    邮箱:sales@thbiochem.com
    通信地址: 江苏省泰州市高港区白马工业园姜高路南7号 天鸿生化
    邮编: 225300
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省泰州市高港区白马工业园姜高路南7号 天鸿生化
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    四川嘉瑛莱科技有限责任公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jiayinglai.com/
    电话: 028-64159575👤
    📞四川嘉瑛莱科技有限责任公司 ⚠️参考联系方式

    销售电话:028-64159575
    邮箱:linda@enlaibio.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海庭园生化科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.gdbiochem.com.cn
    电话: 021-50800786👤
    📞上海庭园生化科技有限公司 ⚠️参考联系方式

    销售电话:021-50800786
    邮箱:sales@gdbiochem.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Studies On Cardiotonic Agents. Iv. Synthesis Of Novel 1-(6,7-Dimethoxy-4-Quinazolinyl)Piperidine Derivatives Carrying Substituted Hydantoin And 2-Thiohydantoin Rings.
    作者:Yuji Nomoto,Haruki Takai,Tadashi Hirata,Masayuki Teranishi,Tetsuji Ohno,Kazuhiro Kubo
    摘要:7-Dimethoxy-4-Quinazolinyl)Piperidines Carrying Substituted Hydantoin And 2-Thiohydantoin Rings Was Synthesized And Examined For Cardiotonic Activity In Anesthetized Dogs. Introduction Of Isopropyl And Sec-Butyl Group At The 5-Position Of The Hydantoin And Thiohydantoin Rings Led To Potent Inotropic Activity. Effects Of Insertion Of An Alkyl Chain Between The Piperidine And The Hydantoin Rings Were

    合成参考文献


    摘要:Ayad, T.; Pirat, J.-L.; Virieux, D., Science of Synthesis Knowledge Updates, (2022) 1, 354.
    摘要:Singh, R. P.; Deng, L., Science of Synthesis: Asymmetric Organocatalysis, (2012) 2, 98.
    摘要:Andries-Ulmer, A.; Gulder, T., Science of Synthesis: Catalytic Oxidation in Organic Synthesis, (2017) 1, 418.
    摘要:Wang, H.-Y.; Zhao, G., Science of Synthesis, (2019) , 232.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知